Zhichao He

107 Yanjiang West Road
Guangzhou, 510120, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Development and Validation of a Rapid Benefit-Risk Assessment Index for Pediatric Off-Label Drug Use.

Development and Validation of a Rapid Benefit-Risk Assessment Index for Pediatric Off-Label Drug Use.

Journal: Journal of evidence-based medicine
Published: January 23, 2026

Risk of Ophthalmotoxicity Associated with Antibody-Drug Conjugates: A Systematic Review and Meta-analysis.

Risk of Ophthalmotoxicity Associated with Antibody-Drug Conjugates: A Systematic Review and Meta-analysis.

Journal: Clinical drug investigation
Published: April 24, 2025

Ophthalmotoxicity induced by antibody-drug conjugates: a pharmacovigilance study of the FDA adverse event reporting system (FAERS).

Ophthalmotoxicity induced by antibody-drug conjugates: a pharmacovigilance study of the FDA adverse event reporting system (FAERS).

Journal: Expert opinion on drug safety
Published: April 09, 2025

Hemorrhage profile associated with immune checkpoint inhibitors: a systematic review and a real-world study based on the FAERS database.

Hemorrhage profile associated with immune checkpoint inhibitors: a systematic review and a real-world study based on the FAERS database.

Journal: Expert opinion on drug safety
Published: April 01, 2024

Hypocalcemia Event Associated with Denosumab: A Real-World Study from FDA Adverse Event Reporting System (FAERS) Database.

Hypocalcemia Event Associated with Denosumab: A Real-World Study from FDA Adverse Event Reporting System (FAERS) Database.

Journal: Therapeutic innovation & regulatory science
Published: February 21, 2024

Gap-free chromosome-level genomes of male and female spotted longbarbel catfish Hemibagrus guttatus.

Gap-free chromosome-level genomes of male and female spotted longbarbel catfish Hemibagrus guttatus.

Journal: Scientific data
Published: September 22, 2023

Interstitial lung disease in patients treated with poly (ADP-ribose) polymerase inhibitors (PARPi): analysis of results from clinical trials and the FDA Adverse Events Reporting System database.

Interstitial lung disease in patients treated with poly (ADP-ribose) polymerase inhibitors (PARPi): analysis of results from clinical trials and the FDA Adverse Events Reporting System database.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 10, 2023

A high-throughput UHPLC-MS/MS method for the determination of eight anti-tumor drugs in plasma.

A high-throughput UHPLC-MS/MS method for the determination of eight anti-tumor drugs in plasma.

Journal: Analytical biochemistry
Published: April 28, 2023

Thromboembolism profiles associated with cyclin-dependent kinase 4/6 inhibitors: a real-world pharmacovigilance study and a systematic review.

Thromboembolism profiles associated with cyclin-dependent kinase 4/6 inhibitors: a real-world pharmacovigilance study and a systematic review.

Journal: Expert opinion on drug safety
Published: February 16, 2023

SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment.

SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment.

Journal: Acta diabetologica
Published: August 26, 2022

Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance study.

Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance study.

Journal: Expert opinion on drug safety
Published: August 05, 2022

Pulmonary tuberculosis associated with immune checkpoint inhibitors: a pharmacovigilance study.

Pulmonary tuberculosis associated with immune checkpoint inhibitors: a pharmacovigilance study.

Journal: Thorax
Published: May 03, 2021
Showing 1-12 of 18

Last Updated: 09/26/2026